The Role of Pro-angiogenic Immune Cells in Human Pregnancies

NCT01177020 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2010-08-06

No results posted yet for this study

Summary

Identification of the presence of proangiogenic immune cells in normal human placentas may enable predication of some pregnancy disorders.

Conditions

Interventions

OTHER

Biological specimen

Biological specimen taken from placenta

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-08-31
Completion
2011-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01177020 on ClinicalTrials.gov